Clark Estates Inc’s United Therapeutics UTHR Stock Holding History

Clark Estates Inc’s Portfolio UTHR Stock Details UTHR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-6,730	Closed	-$2.82M	–	109
2025 Q3	$2.82M	Buy	6,730 +630	+10%	+$212K	0.64%	29
2025 Q2	$1.75M	Buy	+6,100	New	+$1.82M	0.39%	65
2024 Q4	–	Sell	-12,200	Closed	-$4.37M	–	100
2024 Q3	$4.37M	Sell	12,200 -1,000	-8%	-$338K	0.81%	17
2024 Q2	$4.2M	Sell	13,200 -2,300	-15%	-$609K	0.79%	16
2024 Q1	$3.56M	Buy	15,500 +2,000	+15%	+$451K	0.59%	46
2023 Q4	$2.97M	Hold	13,500	–	–	0.5%	69
2023 Q3	$3.05M	Buy	+13,500	New	+$3.11M	0.55%	48
2021 Q2	–	Sell	-21,000	Closed	-$3.51M	–	107
2021 Q1	$3.51M	Hold	21,000	–	–	0.45%	79
2020 Q4	$3.19M	Hold	21,000	–	–	0.45%	75
2020 Q3	$2.12M	Hold	21,000	–	–	0.35%	89
2020 Q2	$2.54M	Buy	+21,000	New	+$2.36M	0.44%	73
2019 Q3	–	Sell	-34,000	Closed	-$2.65M	–	96
2019 Q2	$2.65M	Hold	34,000	–	–	0.42%	76
2019 Q1	$3.99M	Hold	34,000	–	–	0.62%	31
2018 Q4	$3.7M	Hold	34,000	–	–	0.59%	34
2018 Q3	$4.35M	Buy	34,000 +1,000	+3%	+$124K	0.65%	35
2018 Q2	$3.73M	Hold	33,000	–	–	0.56%	49
2018 Q1	$3.71M	Buy	+33,000	New	+$4.19M	0.59%	39

Other funds holding UTHR

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

AssetMark Inc Concord, California $58.2B AUM 22.78% 1-Year Est. Return

Clark Estates Inc's UTHR Position: Q4 2025 in Review

Clark Estates Inc sold out of United Therapeutics (UTHR) in Q4 2025, closing a stake of 6,730 shares — an estimated $2.82M sold.

Clark Estates Inc first reported a position in UTHR in Q1 2018 and held it in 17 quarters. The position peaked at $4.37M in Q3 2024. 838 funds tracked by Wall St. Rank hold UTHR as of Q4 2025.

Clark Estates Inc reported no remaining United Therapeutics position as of Q4 2025 after selling out during the quarter.
Clark Estates Inc sold 6,730 United Therapeutics shares in Q4 2025, an estimated $2.82M.
Clark Estates Inc first reported a position in United Therapeutics in Q1 2018 and held it in 17 quarters.
Clark Estates Inc's United Therapeutics position peaked at $4.37M in Q3 2024.
838 funds tracked by Wall St. Rank held United Therapeutics as of Q4 2025.

Based on Clark Estates Inc's 13F filing for Q4 2025, filed 12 Feb 2026.